June 30, 2009
HealthTronics has agreed to buy Endocare.
A key result of the study shows differences between medical devices and pharmaceuticals.
An update to the recommended rules will go into effect July 1.
Purchase broaden's endovascular device company's neurovascular product portfolio.
The leadership change is slated for July 13.
Boston Scientific study shows a 29 percent reduction in death or heart failure interventions.
Margaret Hamburg will speak in September at the annual RAPS meeting.
Prosecutors charge the orthopedic device maker with promoting off-label use of bone filler Norian XR.
Survey finds optimism among risk-taking investors.
Urge Obama to "consider the value" of the technology
Bill would create national database of patients receiving artificial joints
The gadget allows sharing of information between patients and healthcare providers.
Seattle, Wash.-based company focused on developing cortical stimulation therapies.
Research shows no lab inspections are planned for this year.
Purchase adds Pipeline Embolization Device and Alligator Retrieval Device to portfolio
Major industry groups collaborate to help cut $1 trillion in healthcare costs.
Announcement made during webcast on the OEM's diabetes business.
Please visit our sister sites:
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.